Expanding Precompetitive Multisector Collaborations to Advance Drug Development and Pharmacogenomics.

Drug development requires a myriad of preclinical and clinical studies to understand the pharmacokinetics, efficacy, and toxicity of new drugs in patients. To inform these studies, a common base of knowledge is required. In this commentary, we provide an overview of several multidisciplinary consortia that support precompetitive drug development and pharmacogenomics research. The goal of this commentary is to stimulate awareness of consortia that advance knowledge in clinical pharmacology.